bio.ras_0003.7
Tandem mass spectrometric analysis of tryptic fragments from the bands migrating at the positions expected for mono @- and di @- ubiquitinated Ras revealed ubiquitination at Lys residues 104 and 147 of K @-@ Ras , and Lys residues 117 , 147 and 170 for H @-@ Ras ( fig. S1C ) .
FN set(['be-located-at-91', 'enzyme', 'fragment', '"2"', '"1"', '"trypsin"', '"s1c"', 'or'])

Seen be-located-at-91 52  times
Seen enzyme 521  times
Seen "2" 45  times
Seen "1" 43  times
Seen or 121  times


bio.bmtr_0004.13
We immunoprecipitated Ras from HEK293T cells and compared the sensitivity of the monoubiquitinated and unmodified fractions of Ras to regulation by GAP .
FN set(['"-"', 'sensitive-03', 'modify-01', 'enzyme'])

Seen "-" 218  times
Seen sensitive-03 5  times
Seen modify-01 5  times
Seen enzyme 521  times


bio.bmtr_0004.12
To validate the use of an in vitro system to dissect the mechanism of Ras regulation , we measured the sensitivity of mUbRas to GAP @-@ mediated hydrolysis in a cellular reconstitution system .
FN set(['sensitive-03', '"1"', 'have-purpose-91', 'enzyme', 'reconstitute-01', 'ubiquitinate-01'])

Seen sensitive-03 5  times
Seen "1" 43  times
Seen have-purpose-91 4  times
Seen enzyme 521  times
Seen reconstitute-01 3  times
Seen ubiquitinate-01 1  times


bio.bel_0002.10
In addition , we found that Rheb inhibits the association of B @-@ Raf with H @-@ Ras .
FN set(['enzyme'])

Seen enzyme 521  times


bio.bel_0002.11
hKSR @-@ 2 selectively inhibited the Cot @-@ mediated activation of MEK by 60 % .
FN set(['enzyme'])

Seen enzyme 521  times


bio.bel_0002.12
In contrast , hKSR @-@ 2 up @-@ regulated the Rafmediated MEK activation by up to 70 % .
FN set(['mediate-01', 'upregulate-01', 'enzyme', '"raf"'])

Seen mediate-01 21  times
Seen enzyme 521  times
Seen "raf" 28  times


bio.bel_0002.13
GSK PI3K Phase 2 , part 1: List of non @-@ position specific phosphorylation effects on parent protein 's activity , derived from existing causal assertions of position @-@ specific phosphorylations on the parent protein activity .
FN set(['and', '"1"', 'enzyme', '"gsk"', 'list-01', 'cause-01'])

Seen and 729  times
Seen "1" 43  times
Seen enzyme 521  times
Seen cause-01 128  times


bio.bel_0002.7
Following expression of BRAFV600E in melanocytes , the majority of cells became senescent ( Figure 1D and data not shown ) , consistent with previous studies ( Michaloglou et al. , 2005 )
FN set(['melanocyte', 'study', '"v600e"', 'enzyme', '"b-raf"', 'mutate-01'])

Seen study 6  times
Seen enzyme 521  times
Seen "b-raf" 5  times
Seen mutate-01 148  times


bio.bel_0002.4
The homologous site on B @-@ Raf , S445 , is constitutively phosphorylated , accounting for the higher basal activity of B @-@ Raf .
FN set(['homologue', 'enzyme'])

Seen enzyme 521  times


bio.bel_0002.5
In addition , introduction of B @-@ Raf enhances and sustains integrin @-@ mediated activation of ERK in wild @-@ type primary fibroblasts
FN set(['enzyme', 'integrin'])

Seen enzyme 521  times


bio.bel_0002.2
We show that wild @-@ type B @-@ RAF forms a complex with C @-@ RAF in a RAS @-@ dependent manner , whereas the mutants bind independently of RAS .
FN set(['enzyme', 'macro-molecular-complex'])

Seen enzyme 521  times
Seen macro-molecular-complex 107  times


bio.bmtr_0001.21
These results are consistent with a greater fraction of ubiquitinated K @-@ Ras being in the GTP state ( Fig . 2 , A and B ) .
FN set(['enzyme', 'small-molecule', 'bind-01'])

Seen enzyme 521  times
Seen small-molecule 89  times
Seen bind-01 110  times


bio.bmtr_0001.20
However , a much greater fraction of the ubiquitinated @-@ K @-@ Ras was pulled down by the GST @-@ RBD ( Fig . 2C and fig. S1D ) .
FN set(['enzyme', 'pull-00'])

Seen enzyme 521  times


bio-kappa_0001.8
Phosphorylated Ksr can also function as a transactivator ; however , since Raf binding to Ksr induces limited kinase activity , in quiescent cells the constitutive association of Ksr with B @-@ Raf may serve to prevent C @-@ Raf binding to B @-@ Raf , safeguarding against undue activation of the pathway .
FN set(['"-"', 'due', 'enzyme', 'transactivate-00', 'act-01'])

Seen "-" 218  times
Seen enzyme 521  times
Seen transactivate-00 1  times
Seen act-01 40  times


bio-kappa_0001.9
PSPs dephosphorylate phosphoserine and phosphothreonine residues .
FN set(['"threonine"', 'amino-acid', 'small-molecule', '"psp"', 'phosphorylate-01', '"serine"'])

Seen "threonine" 3  times
Seen amino-acid 51  times
Seen small-molecule 89  times
Seen phosphorylate-01 38  times


bio-kappa_0001.1
Activation of Raf occurs via a complex , yet incompletely understood mechanism requiring membrane translocation , regulatory phosphorylation / dephosphorylation events and , crucially , allosteric activation in the context of a side @-@ to @-@ side dimer comprising two Raf molecules or a Raf and a Ksr molecule .
FN set(['have-part-91', 'enzyme', 'complex', 'side-to-side', 'dimer'])

Seen have-part-91 5  times
Seen enzyme 521  times
Seen complex 8  times


bio-kappa_0001.2
Of the three Raf kinases , only B @-@ Raf is able to function as an allosteric activator in the context of the Raf heterodimers , a role independent of B @-@ Raf kinase activity .
FN set(['enzyme', 'have-part-91'])

Seen enzyme 521  times
Seen have-part-91 5  times


bio-kappa_0001.3
The molecular basis for this has recently been elucidated by the Shaw lab , who has shown that the ability of acting as an activator depends on the presence of negative charges in the Raf N @-@ terminal acidic motif .
FN set(['enzyme', 'motif', 'possible', 'present', 'base-02', 'mechanism', 'charge', '"n-terminus"'])

Seen enzyme 521  times
Seen motif 1  times
Seen possible 184  times
Seen present 12  times
Seen base-02 5  times
Seen mechanism 11  times
Seen charge 1  times


bio-kappa_0001.4
In B @-@ Raf , this motif is negatively charged due to the constitutive phosphorylation of Ser446 and @/@ or 447 , and to the presence of two aspartates at position 448 @/@ 9 ( Fig. 2A ) .
FN set(['motif', 'negative', '"aspartate"', 'enzyme', 'charge-03', '"449"'])

Seen motif 1  times
Seen negative 3  times
Seen enzyme 521  times


bio-kappa_0001.5
Allosteric activation by B @-@ Raf induces cis @-@ autophosporylation in the activation loop of the receiver kinase , i.e. C @-@ Raf , and renders it able to phosphorylate Mek .
FN set(['enzyme', 'receive-01', 'render-01'])

Seen enzyme 521  times
Seen receive-01 1  times


bio-kappa_0001.6
Mek , in turn , phosphorylates the N @-@ terminal acidic motif in C @-@ Raf , converting it to an allosteric activator of other Rafs ( Fig. 2B and C ) .
FN set(['motif', 'enzyme', '"raf"', '"2c"'])

Seen motif 1  times
Seen enzyme 521  times
Seen "raf" 28  times
Seen "2c" 3  times


bio-kappa_0001.7
This model explains why C @-@ Raf mutants devoid of kinase activity cannot function as activators , and why B @-@ Raf can activate Mek directly as a homodimer .
FN set(['enzyme', 'kinase', 'act-01'])

Seen enzyme 521  times
Seen kinase 29  times
Seen act-01 40  times


bio.bmtr_0001.8
Tandem mass spectrometric analysis of tryptic fragments from the bands migrating at the positions expected for mono @- and di @-@ ubiquitinated Ras revealed ubiquitination at Lys residues 104 and 147 of K @-@ Ras , and Lys residues 117 , 147 and 170 for H @-@ Ras ( fig . S1C ) .
FN set(['"1"', 'hydrolyze-01', '"trypsin"', 'enzyme', 'be-located-at-91', 'or'])

Seen "1" 43  times
Seen hydrolyze-01 10  times
Seen enzyme 521  times
Seen be-located-at-91 52  times
Seen or 121  times


bio.bmtr_0001.9
The tryptic peptide with ubiquitination at Lys147 ( K147 ) was the most frequently observed peptide for both K @-@ Ras and H @-@ Ras , while Lys117 appeared as a secondary major ubiquitination site in H @-@ Ras .
FN set(['hydrolyze-01', 'appear-01', '"trypsin"', 'enzyme', 'or'])

Seen hydrolyze-01 10  times
Seen appear-01 8  times
Seen enzyme 521  times
Seen or 121  times


bio.bmtr_0001.1
Sasaki et al. , “ Ubiquitination of Ras enhances activation and facilitates binding to select downstream effectors ” ( PMC3437993 )
FN set(['enzyme', 'publication-91'])

Seen enzyme 521  times
Seen publication-91 136  times


bio.bmtr_0001.2
We utilized an unbiased mass spectrometry @-@ based approach to identify ubiquitination sites of Ras .
FN set(['enzyme'])

Seen enzyme 521  times


bio.bmtr_0001.3
His @-@ tagged ubiquitin and Flag @-@ tagged K @-@ Ras4B ( K @-@ Ras hereafter ) were expressed in HEK293T cells at levels similar to endogenous K @-@ Ras ( Fig . 1B ) and subjected to sequential affinity chromatography .
FN set(['protein-segment', 'sequence', 'enzyme', 'endogenous'])

Seen protein-segment 69  times
Seen sequence 6  times
Seen enzyme 521  times
Seen endogenous 8  times


bio.bmtr_0001.4
His @-@ ubiquitinated proteins were purified by Co2+ metal affinity chromatography in 8M urea denaturing conditions .
FN set(['molar', 'amino-acid', '"histidine"', 'small-molecule', 'concentration-quantity', '"8"'])

Seen molar 2  times
Seen amino-acid 51  times
Seen "histidine" 5  times
Seen small-molecule 89  times
Seen concentration-quantity 14  times
Seen "8" 4  times


bio.bmtr_0001.5
His @-@ ubiquitinated K @-@ Ras was subsequently purified with anti @-@ Flag resin .
FN set(['protein-segment', 'enzyme'])

Seen protein-segment 69  times
Seen enzyme 521  times


bio.bmtr_0001.6
Following purification , mono @- and di @- ubiquitinated K @-@ Ras appeared to be the major ubiquitination forms , which is consistent with the endogenous K @-@ Ras ubiquitination pattern ( Fig . 1 , A and B ) .
FN set(['or', '"1"', 'have-quant-91', 'appear-02', 'most', 'enzyme', '"2"'])

Seen or 121  times
Seen "1" 43  times
Seen have-quant-91 1  times
Seen appear-02 28  times
Seen most 32  times
Seen enzyme 521  times
Seen "2" 45  times


bio.bmtr_0001.7
H @-@ Ras ubiquitination sites were also determined by the same approach .
FN set(['enzyme', 'same'])

Seen enzyme 521  times
Seen same 1  times


bio.bmtr_0003.8
Serial deletions identified a minimal HER3 promoter retaining transcriptional response to vemurafenib and AZD6244 , which was located between -@ 401 and -@ 42 bp ( Fig . 5C ) .
FN set(['"-42"', 'transcribe-01', 'distance-quantity', 'serial', 'small-molecule', '"-401"', 'thing', 'enzyme', 'between', 'base-pair', 'minimal'])

Seen transcribe-01 24  times
Seen distance-quantity 6  times
Seen small-molecule 89  times
Seen thing 97  times
Seen enzyme 521  times
Seen between 16  times


bio.bmtr_0003.9
This region does not contain any predicted FoxO binding sites .
FN set(['protein-segment'])

Seen protein-segment 69  times


bio.bmtr_0005.10
An in vitro phophorylation assay was performed with a purified C @-@ terminus fragment of ASPP2 ( 693 @-@ 1128 ) containing both MAPK putative phosphorylation sites .
FN set(['both', 'amino-acid', 'enzyme', 'between'])

Seen amino-acid 51  times
Seen enzyme 521  times
Seen between 16  times


bio.bmtr_0003.2
We next examined the mechanisms accounting for the increase in HER3 by MAPK pathway inhibitors in BRAF mutant thyroid cell lines .
FN set(['enzyme', 'dna', 'encode-01'])

Seen enzyme 521  times
Seen dna 10  times
Seen encode-01 11  times


bio.bmtr_0003.3
Upregulation of HER3 has been found to mediate resistance to PI3K @/@ AKT ( 26 ) or HER2 ( 27 ) inhibitors in HER2 @-@ amplified breast cancer cell lines , which is caused in part through a FoxO3A @-@ dependent induction of HER3 gene transcription .
FN set(['"pi3k/akt"', 'encode-01', 'mediate-01', 'transcribe-01', 'upregulate-01', 'enzyme', 'pathway'])

Seen encode-01 11  times
Seen mediate-01 21  times
Seen transcribe-01 24  times
Seen enzyme 521  times
Seen pathway 80  times


bio.bmtr_0003.1
Montero @-@ Conde et al. “ Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF mutant thyroid carcinomas.” ( PMC3651738 )
FN set(['carcinoma', 'counter-01', 'publication-91', 'dna', 'encode-01', 'tumor', 'enzyme', 'gene'])

Seen carcinoma 6  times
Seen counter-01 73  times
Seen publication-91 136  times
Seen dna 10  times
Seen encode-01 11  times
Seen tumor 28  times
Seen enzyme 521  times
Seen gene 106  times


bio.bmtr_0003.6
The effects of the MEK inhibitor on total HER2 , HER3 protein and on pHER3 were dose dependent , and inversely associated with the degree of inhibition of pERK ( Fig . 5B ) .
FN set(['dose-01', 'phosphorylate-01', 'thing', 'enzyme'])

Seen phosphorylate-01 38  times
Seen thing 97  times
Seen enzyme 521  times


bio.bmtr_0003.7
RAF or MEK inhibitors induced luciferase activity of a HER3 promoter construct spanning ~ 1 kb upstream of the transcriptional start site in 8505C cells .
FN set(['site', 'cell', 'enzyme', 'act-01'])

Seen site 7  times
Seen cell 193  times
Seen enzyme 521  times
Seen act-01 40  times


bio.bmtr_0003.4
As shown in Fig. 5A , PLX4032 treatment increased HER3 and HER2 mRNAs in all six BRAF @-@ mutant thyroid cancer cell lines tested .
FN set(['all', 'test-01', '"6"', 'dna', 'encode-01', 'small-molecule', 'treat-04', 'enzyme', 'mrna'])

Seen all 14  times
Seen test-01 9  times
Seen "6" 8  times
Seen dna 10  times
Seen encode-01 11  times
Seen small-molecule 89  times
Seen treat-04 32  times
Seen enzyme 521  times


bio.bmtr_0003.5
Similar results were found following treatment with the MEK inhibitor AZD6244 ( not shown ) .
FN set(['thing', 'enzyme', 'small-molecule'])

Seen thing 97  times
Seen enzyme 521  times
Seen small-molecule 89  times


bio.bmtr_0005.8
The ASPP1 sites are at residues 671 and 746 , and the ASPP2 sites are at residues 698 and 827 ( Figure 1A ) .
FN set(['amino-acid'])

Seen amino-acid 51  times


bio.bmtr_0005.9
We thus tested whether RAS activation may regulate ASPP2 phosphorylation .
FN set(['enzyme', '"interrogative"'])

Seen enzyme 521  times
Seen "interrogative" 18  times


bio.bmtr_0005.4
Mechanistically ASPP1 and ASPP2 bind RAS @-@ GTP and potentiates RAS signalling to enhance p53 mediated apoptosis [2].
FN set(['cite-01', '"2"', 'signal-07', 'macro-molecular-complex', 'small-molecule', 'describe-01', 'enzyme', 'publication'])

Seen cite-01 75  times
Seen "2" 45  times
Seen signal-07 74  times
Seen macro-molecular-complex 107  times
Seen small-molecule 89  times
Seen describe-01 404  times
Seen enzyme 521  times
Seen publication 66  times


bio.bmtr_0005.5
As RAS is upstream of several signalling cascades [13], we queried whether the activity of ASPP2 is regulated by the activation of a RAS @-@ mediated signalling pathway .
FN set(['"13"', 'publication', 'describe-01', 'cite-01', 'enzyme'])

Seen "13" 6  times
Seen publication 66  times
Seen describe-01 404  times
Seen cite-01 75  times
Seen enzyme 521  times


bio.ras_0002.5
In addition , scaffold proteins have been shown to guide activation of specific effector pathway( s ) . For example , SHOC2 / Sur @-@ 8 bridges Ras and Raf to specifically enhance the Raf / MEK / ERK pathway without enhancing PI3K / AKT signaling ( 9 , 10 ) .
FN set(['"pi3k/akt"', 'macro-molecular-complex', '"raf/mek/erk"', 'multi-sentence', 'bridge-01', 'enzyme'])

Seen macro-molecular-complex 107  times
Seen multi-sentence 20  times
Seen enzyme 521  times


bio.bmtr_0005.7
Interestingly , we observed two conserved putative MAPK phosphorylation sites in ASPP1 and ASPP2 .
FN set(['interest-01', 'pathway'])

Seen interest-01 5  times
Seen pathway 80  times


bio.ras_0002.3
The enhancement of specific effector pathways plays a critical role in maintaining an appropriate biological response ( 8 ) .
FN set(['thing'])

Seen thing 97  times


bio.bmtr_0005.1
Phosphorylation of ASPP2 by RAS @/@ MAPK Pathway Is Critical for Its Full Pro @-@ Apoptotic Function ( PMC3847091 )
FN set(['"ras/mapk"', 'publication-91'])

Seen publication-91 136  times


bio.ras_0002.1
Activated Ras controls diverse signaling pathways that ultimately determine Ras - induced cellular responses such as cell proliferation , survival , differentiation and motility .
FN set(['enzyme'])

Seen enzyme 521  times


bio.bmtr_0005.3
It has recently been shown that oncogenic RAS can enhance the apoptotic function of p53 via ASPP1 and ASPP2 .
FN set(['enzyme'])

Seen enzyme 521  times


bio.bmtr_0001.12
Interestingly , the ubiquitinated subfraction of wild @-@ type K @-@ Ras retained a significant amount of 32P @-@ GTP .
FN set(['"32"', 'subfraction', 'phosphorus', 'interest-01', 'significant-02', 'small-molecule', 'enzyme', 'molecular-mass'])

Seen "32" 5  times
Seen interest-01 5  times
Seen significant-02 5  times
Seen small-molecule 89  times
Seen enzyme 521  times


bio.bmtr_0001.13
These results are consistent with a model in which ubiquitination of Lys147 ( or Lys117 ) , destabilizes GDP binding , allowing spontaneous GDP @/@ GTP exchange .
FN set(['small-molecule', 'spontaneous'])

Seen small-molecule 89  times


bio.bmtr_0001.10
To examine the effect of ubiquitination on GTP loading , we purified wild @-@ type K @-@ Ras , oncogenic G12V @-@ K @-@ Ras mutant or the ubiquitinated subfraction of wild @-@ type K @-@ Ras from 32P @-@ orthophosphate labeled cells and utilized thin layer chromatography ( TLC ) and high performance liquid chromatography ( HPLC ) to assess the ratio of 32P @-@ GTP to 32P @-@ GDP that co @-@ purified with each form of K @-@ Ras .
FN set(['"32"', 'small-molecule', 'enzyme', 'subfraction', 'molecular-mass', 'phosphorus'])

Seen "32" 5  times
Seen small-molecule 89  times
Seen enzyme 521  times


bio.bmtr_0001.11
As expected based on previous studies , wild @-@ type K @-@ Ras bound primarily 32P @-@ GDP , while G12V @-@ Ras bound 32P @-@ GTP ( Fig.2 , A and B ) .
FN set(['"32"', 'small-molecule', 'study', 'enzyme', 'molecular-mass', 'phosphorus'])

Seen "32" 5  times
Seen small-molecule 89  times
Seen study 6  times
Seen enzyme 521  times


bio.bmtr_0001.16
These results , along with the crystal structure , support a model in which mono @-@ ubiquitination at a Lys residue directly involved in GDP binding either enhances nucleotide exchange on K @-@ Ras , impairs GTP hydrolysis , or both .
FN set(['and', 'enzyme', 'small-molecule'])

Seen and 729  times
Seen enzyme 521  times
Seen small-molecule 89  times


bio.bmtr_0001.17
To corroborate this finding , we measure the activity of Ras by the GST @-@ RBD pull @-@ down assay .
FN set(['thing', 'enzyme'])

Seen thing 97  times
Seen enzyme 521  times


bio.bmtr_0001.14
It could be argued that GTP loading occurs prior to ubiquitination and that the GTP bound form of K @-@ Ras , via interaction with effectors , is preferentially mono @-@ ubiquitinated via a feedback mechanism .
FN set(['enzyme', 'small-molecule'])

Seen enzyme 521  times
Seen small-molecule 89  times


bio.bmtr_0001.15
While it is difficult to eliminate this possibility , it is unlikely since , as shown in fig. S1B , the T35 mutant of K @-@ Ras , which fails to interact with downstream effectors ( fig . S1B ) undergoes comparable monobuiquitination to wild type Ras .
FN set(['comparable', '"1"', 'enzyme', 'ubiquitinate-01'])

Seen "1" 43  times
Seen enzyme 521  times
Seen ubiquitinate-01 1  times


bio.bmtr_0001.18
To ensure that ubiquitinated Ras was being detected , the protein pulled down by GST @-@ RBD was subjected to a second affinity purification on a cobalt column to purify the Flag @-@ His @-@ tagged K @-@ Ras .
FN set(['and', 'protein-segment', 'enzyme', 'pull-00'])

Seen and 729  times
Seen protein-segment 69  times
Seen enzyme 521  times


bio.bmtr_0001.19
As predicted , only a very small fraction of wild @-@ type K @-@ Ras was pulled down by the GST @-@ RBD ( Fig . 2C and fig. S1D ) , consistent with very little wild @-@ type K @-@ Ras being in the GTP state under these conditions ( Fig.2 , A and B ) .
FN set(['enzyme', 'small-molecule', 'bind-01'])

Seen enzyme 521  times
Seen small-molecule 89  times
Seen bind-01 110  times


bio.bmtr_0005.6
One of the most studied downstream pathways of RAS signalling is the Raf @-@ MAPK pathway .
FN set(['enzyme', 'signal-07'])

Seen enzyme 521  times
Seen signal-07 74  times


bio.ras_0002.4
The specificity in Ras - induced signaling is primarily determined by the balance between Ras affinity for each of its effectors and the local concentrations of those effectors .
FN set(['enzyme'])

Seen enzyme 521  times


bio.bmtr_0004.24
The analysis revealed that monoubiquitination abrogates GAP @-@ mediated GTP hydrolysis .
FN set(['small-molecule'])

Seen small-molecule 89  times


bio.bmtr_0004.25
All other activities , including the ability to bind regulators , were largely preserved and our kinetic modeling suggests that the GAP defect will dominate .
FN set(['possible', 'model-01', 'kinetic', 'act-02'])

Seen possible 184  times
Seen kinetic 1  times
Seen act-02 19  times


bio.bmtr_0004.26
Furthermore , this outcome was specific to monoubiquitination at position 147 .
FN set(['amino-acid'])

Seen amino-acid 51  times


bio.bmtr_0004.27
Thus our work establishes an entirely new mode of Ras activation in which signaling is sustained even in the absence of hormone stimulus or oncogene mutation .
FN set(['enzyme', 'lack-01', 'cancer'])

Seen enzyme 521  times
Seen lack-01 11  times
Seen cancer 44  times


bio.bmtr_0004.20
This chemical ligation strategy will likely be useful for the study of other monoubiquitinated proteins .
FN set(['useful'])

Seen useful 1  times


bio.bmtr_0004.21
Surprisingly , monoubiquitination did not alter the intrinsic activity of Ras , despite the size of the modification .
FN set(['thing', 'enzyme'])

Seen thing 97  times
Seen enzyme 521  times


bio.bmtr_0004.22
Our modeling and NMR analyses indicated that Ubiquitin dynamically samples a broad surface area of Ras that alters switch region dynamics .
FN set(['nmr', 'switch-01', 'enzyme', 'model-01'])

Seen switch-01 2  times
Seen enzyme 521  times


bio.bmtr_0004.23
These results led us to examine the effect of monoubiquitination on the interaction of Ras with its cognate GEF and GAPs , which also target the switch domains .
FN set(['switch-01', 'enzyme', 'cognate'])

Seen switch-01 2  times
Seen enzyme 521  times


bio-kappa_0001.18
Following ligand binding , Sos is brought from the cytoplasm to the activated receptor in a phosphotyrosine - dependent manner through adapter proteins such as Grb2 .
FN set(['adapter', '"sos"'])

Seen "sos" 13  times


bio-kappa_0001.19
Grb2 contains SH3 domains that are bound constitutively to a carboxy - terminal proline - rich region of Sos , and the Grb2 ' 96 Sos complex is recruited to activated receptors by interactions between the SH2 domain of Grb2 and phosphotyrosine residues on the receptor .
FN set(['macro-molecular-complex', '"carboxy-terminus"'])

Seen macro-molecular-complex 107  times


bio.bmtr_0005.2
Passage 1 @-@ 1 ( Results )
FN set(['thing', '"1-1"', 'passage'])

Seen thing 97  times


bio-kappa_0001.12
A similar role in C @-@ Raf activation has been described for the catalytic subunit of PP1C , which associates with C @-@ Raf in Ras @- and growth factor - stimulated cells .
FN set(['protein-segment', 'small-molecule', 'enzyme', 'catalyze-01', 'bind-01'])

Seen protein-segment 69  times
Seen small-molecule 89  times
Seen enzyme 521  times
Seen catalyze-01 3  times
Seen bind-01 110  times


bio-kappa_0001.13
In addition to promoting C @-@ Raf activation , PP2A is also able to dephosphorylate Erk - dependent sites on C @-@ Raf .
FN set(['protein-segment', 'promote-02', 'also', 'enzyme'])

Seen protein-segment 69  times
Seen promote-02 1  times
Seen also 46  times
Seen enzyme 521  times


bio-kappa_0001.10
One of the most abundantly expressed PSPs , protein phosphatase 2A ( PP2A ) , can regulate the Raf / Mek / Erk pathway both positively and negatively .
FN set(['"raf/mek/erk"', 'upregulate-01', '"psp"', 'abundant', 'small-molecule', 'include-91', 'enzyme', 'express-03'])

Seen small-molecule 89  times
Seen include-91 42  times
Seen enzyme 521  times
Seen express-03 144  times


bio-kappa_0001.11
As a positive regulator , PP2A associates with C @-@ Raf and Ksr1 and dephosphorylates negative regulatory sites on both proteins , allowing their recruitment to the membrane and leading to Mek and Erk activation .
FN set(['protein-segment', 'downregulate-01', 'upregulate-01', 'enzyme'])

Seen protein-segment 69  times
Seen downregulate-01 33  times
Seen enzyme 521  times


bio-kappa_0001.16
A further negative regulator of the cascade , at the level of C @-@ Raf , is Protein phosphatase 5 ( PP5 ) , which associates with C @-@ Raf via its N @-@ terminal tetratricopeptide ( TPR ) domain in growth factor stimulated cells .
FN set(['"domain"', 'downregulate-01', 'small-molecule', 'cascade', 'enzyme', '"n-terminal"'])

Seen "domain" 25  times
Seen downregulate-01 33  times
Seen small-molecule 89  times
Seen cascade 4  times
Seen enzyme 521  times


bio-kappa_0001.17
This interaction leads to the activation of PP5 catalytic activity and to the selective dephosphorylation of the activating serine residue at position 338 , terminating the signal .
FN set(['enzyme', 'catalyze-01', 'signal'])

Seen enzyme 521  times
Seen catalyze-01 3  times
Seen signal 8  times


bio-kappa_0001.14
Since the sites have been described alternatively as negative regulatory or activating , the significance of these dephosphorylation events for Raf activation is unclear .
FN set(['protein-segment', 'downregulate-01', 'enzyme', 'significance', 'cause-01'])

Seen protein-segment 69  times
Seen downregulate-01 33  times
Seen enzyme 521  times
Seen cause-01 128  times


bio-kappa_0001.15
As a negative regulator of the pathway , PP2A can dephosphorylate the adapter protein Shc , required downstream of some tyrosine kinase receptors for the activation of the Raf / Mek / Erk module ; and it can dephosphorylate Mek and Erk proteins , thus inhibiting the cascade directly .
FN set(['"raf/mek/erk"', '"module"', '"receptor"', 'cascade', 'enzyme'])

Seen "receptor" 3  times
Seen cascade 4  times
Seen enzyme 521  times


bio.bel_0002.8
disruption of the KSR1 @/@ CK2 interaction or inhibition of CK2 activity significantly reduces the growth @-@ factor @-@ induced phosphorylation of C @-@ Raf and B @-@ Raf on the activating serine site in the negative @-@ charge regulatory region ( N @-@ region ) .
FN set(['significant-02', 'small-molecule', '"factor"', 'enzyme', 'charge-03', '"growth"'])

Seen significant-02 5  times
Seen small-molecule 89  times
Seen "factor" 13  times
Seen enzyme 521  times
Seen "growth" 8  times


bio.ras_0002.2
These multiple Ras functions depend on its binding to a range of functionally diverse effector molecules such as Raf , PI3K , AF6 and RASSFs ( 1 ) .
FN set(['thing', 'enzyme', '"rassf"'])

Seen thing 97  times
Seen enzyme 521  times


bio.bmtr_0002.10
In cells transfected with wild @-@ type EGFR , MEK inhibition led to feedback activation of phospho @-@ ERBB3 and phosho @-@ EGFR , recapitulating the results we had observed in our panel of cancer cell lines ( Figure 6A ) .
FN set(['thing', 'enzyme'])

Seen thing 97  times
Seen enzyme 521  times


bio.bel_0002.9
Sorafenib is a potent TKI of VEGFR @-@ 2 , VEGFR @-@ 3 , B @-@ RAF , and PDGFR @-@ B
FN set(['small-molecule', '"sorafenib"', 'kinase', 'inhibit-01'])

Seen small-molecule 89  times
Seen "sorafenib" 3  times
Seen kinase 29  times
Seen inhibit-01 50  times


bio.mskcc_0001.18
Consistent with these data , we found that B @-@ Raf interacted with C @-@ Raf in an inducible and transient manner following growth factor treatment ( Fig . 3B and C ) .
FN set(['enzyme', 'small-molecule'])

Seen enzyme 521  times
Seen small-molecule 89  times


bio-kappa_0001.27
In principle , these reactions are fast and fully reversible , so that the GEF merely acts as a catalyst to increase the rate at which equilibrium between the GDP @- and GTP - bound forms of the protein is reached .
FN set(['in-principle', 'small-molecule', 'possible', 'reverse-01', 'catalyze-01', 'act-01'])

Seen small-molecule 89  times
Seen possible 184  times
Seen reverse-01 6  times
Seen catalyze-01 3  times
Seen act-01 40  times


bio-kappa_0001.26
This series of reactions is reversed by rebinding of nucleotide , predominantly GTP , because of its higher concentration in the cell .
FN set(['again', 'small-molecule', 'mean-01', 'bind-01'])

Seen again 5  times
Seen small-molecule 89  times
Seen mean-01 56  times
Seen bind-01 110  times


bio-kappa_0001.25
The mechanism of GEF action involves a series of fast reaction steps , which lead from a binary protein - nucleotide complex via a trimeric GNBP - nucleotide - GEF complex to a binary nucleotide - free complex , which is stable in the absence of nucleotide .
FN set(['absent', 'macro-molecular-complex', 'turn-02'])

Seen absent 1  times
Seen macro-molecular-complex 107  times


bio-kappa_0001.24
It is also intrinsically very slow and thus has to be accelerated by GTPase - activating proteins ( GAPs ) .
FN set(['enzyme'])

Seen enzyme 521  times


bio-kappa_0001.23
The switch - OFF process is entirely different and involves hydrolysis of GTP to GDP , the guanosine triphosphatase ( GTPase ) reaction , which is basically irreversible .
FN set(['reverse-01', 'possible', 'deactivate-01', 'small-molecule', 'enzyme'])

Seen reverse-01 6  times
Seen possible 184  times
Seen deactivate-01 4  times
Seen small-molecule 89  times
Seen enzyme 521  times


bio-kappa_0001.22
This switch - ON process involves the exchange of GDP for GTP , and is , at least in principle , reversible .
FN set(['in-principle', 'activate-01', 'small-molecule', 'possible', 'reverse-01'])

Seen activate-01 113  times
Seen small-molecule 89  times
Seen possible 184  times
Seen reverse-01 6  times


bio-kappa_0001.21
Activation requires dissociation of protein - bound GDP , an intrinsically slow process that is accelerated by guanine nucleotide ' 96 exchange factors ( GEFs ) .
FN set(['small-molecule', '"factor"', '"exchange"'])

Seen small-molecule 89  times
Seen "factor" 13  times
Seen "exchange" 4  times


bio-kappa_0001.20
The guanine nucleotide @-@ binding switch in three dimensions .
FN set(['switch', '"nucleotide-binding"'])

Seen switch 4  times


bio.mskcc_0001.53
Through mutational analysis , we find that feedback phosphorylation disrupts the abilities of B @-@ Raf to bind activated Ras and to heterodimerize with C @-@ Raf .
FN set(['enzyme'])

Seen enzyme 521  times


bio.mskcc_0001.52
As has been observed for C @-@ Raf , we find that the hyperphosphorylated B @-@ Raf protein is subsequently dephosphorylated in a manner requiring the activities of the PP2A phosphatase and Pin1 prolyl @-@ isomerase , indicating that the feedback phosphorylation @/@ dephosphorylation cycle is a conserved regulatory mechanism for the Raf proteins .
FN set(['hyperphosphorylate-00', 'conserve-01', 'after', 'enzyme', 'phosphatase', 'prolyl-isomerase'])

Seen hyperphosphorylate-00 1  times
Seen conserve-01 3  times
Seen after 36  times
Seen enzyme 521  times


bio.mskcc_0001.51
These residues are phosphorylated by activated ERK in vitro ,
FN set(['enzyme'])

Seen enzyme 521  times


bio.mskcc_0001.50
Through metabolic labeling experiments , we find here that in addition to the S750 and T753 sites , B @-@ Raf is feedback phosphorylated on two other sites , S151 and T401 .
FN set(['enzyme', 'metabolism'])

Seen enzyme 521  times
Seen metabolism 1  times


bio.mskcc_0001.57
Taken together , these findings suggest a model whereby the binding of a 14 @-@ 3 @-@ 3 dimer to the C @-@ terminal pS621 site of C @-@ Raf and the C @-@ terminal pS729 site of B @-@ Raf provides the stable docking event that then allows the two proteins to make additional contacts ( Fig . 9 ) .
FN set(['after', 'enzyme', 'phosphorylate-01', 'dimer'])

Seen after 36  times
Seen enzyme 521  times
Seen phosphorylate-01 38  times


bio.bmtr_0003.20
MAPK inhibition may dictate a chromatin redistribution of these repressors , and thus activate HER3 transcription .
FN set(['chromatin', 'repress-01', 'redistribute-01', 'enzyme', 'molecular-physical-entity', 'pathway'])

Seen repress-01 10  times
Seen enzyme 521  times
Seen molecular-physical-entity 102  times
Seen pathway 80  times


bio.mskcc_0001.55
This finding is consistent with those of peptide binding studies conducted by Rushworth et al. ( 27 ) indicating that there are multiple points of contact between heterodimerized B @-@ Raf and C @-@ Raf proteins .
FN set(['thing', 'enzyme', 'heterodimerize-00'])

Seen thing 97  times
Seen enzyme 521  times


bio.mskcc_0001.54
Although phosphorylation of the S151 site appears to have the greatest effect on Ras binding , our results indicate that phosphorylation of all the feedback sites contributes to the inhibition of C @-@ Raf binding .
FN set(['enzyme'])

Seen enzyme 521  times


bio-exp_0001.9
Moreover , PLX4032 led to an increase in phosphorylation of FoxO1 @/@ 3A between 4 – 10 h after addition of compound ( not shown ) , which is known to promote its dissociation from DNA , and likely discards involvement of these factors as transcriptional regulators of HER3 in response to MAPK pathway inhibition .
FN set(['"foxo1/3a"', 'small-molecule', 'enzyme', 'molecular-physical-entity'])

Seen small-molecule 89  times
Seen enzyme 521  times
Seen molecular-physical-entity 102  times


bio-exp_0001.8
This region does not contain any predicted FoxO binding sites .
FN set(['protein-segment'])

Seen protein-segment 69  times


bio.bmtr_0002.3
We used tandem mass spectrometry to measure the effects of AZD6244 on phosphorylation of this JM domain threonine residue in both EGFR @-@ mutant and HER2 @- amplified cancer models .
FN set(['this', 'small-molecule', 'enzyme', 'affect-01'])

Seen this 182  times
Seen small-molecule 89  times
Seen enzyme 521  times
Seen affect-01 32  times


bio.bmtr_0002.2
We hypothesized that the MEK @/@ ERK pathway may suppress trans @-@ phosphorylation of ERBB3 by directly phosphorylating the JM domains of EGFR and HER2 , and that this could be a dominant MEK inhibitor @-@ induced feedback leading to AKT activation in these cancers .
FN set(['enzyme', '"mek/erk"'])

Seen enzyme 521  times


bio.mskcc_0001.3
To activate the Raf proteins , autoinhibition mediated by the N terminus must be relieved and the kinase domain must adopt the active catalytic conformation
FN set(['domain', 'kinase', 'require-01', 'enzyme', 'catalyze-01', '"n-terminus"', 'inhibit-01'])

Seen domain 3  times
Seen kinase 29  times
Seen require-01 18  times
Seen enzyme 521  times
Seen catalyze-01 3  times
Seen inhibit-01 50  times


bio.mskcc_0001.2
14 @-@ 3 @-@ 3 dimers bind to phosphorylation sites present in both the N @- and C @-@ terminal regions and stabilize the autoinhibited state ( 22 ) .
FN set(['"n-terminus"', 'inhibit-01'])

Seen inhibit-01 50  times


bio.mskcc_0001.1
We identify four S/TP sites of B @-@ Raf phosphorylated by activated ERK and find that feedback phosphorylation of B @-@ Raf inhibits binding to activated Ras and disrupts heterodimerization with C @-@ Raf , which is dependent on the B @-@ Raf pS729 @/@ 14 @-@ 3 @-@ 3 binding site .
FN set(['"threonine"', 'enzyme', 'or'])

Seen "threonine" 3  times
Seen enzyme 521  times
Seen or 121  times


bio.mskcc_0001.7
In regard to C @-@ Raf , ERK @-@ dependent feedback phosphorylation has been shown to instigate a regulatory cycle whereby phosphorylation of the feedback sites down @-@ modulates C @-@ Raf signaling , after which the hyperphosphorylated C @-@ Raf protein is dephosphorylated and returned to a signaling @-@ competent state through dephosphorylation events involving protein phosphatase 2A ( PP2A ) and the Pin1 prolyl @-@ isomerase ( 8 ) .
FN set(['activate-01', 'downmodulate-00', 'enzyme', 'prolyl-isomerase'])

Seen activate-01 113  times
Seen enzyme 521  times


bio.mskcc_0001.6
Strikingly , the Raf proteins themselves are also substrates of activated ERK .
FN set(['strike-04', 'catalyze-01', 'enzyme'])

Seen strike-04 1  times
Seen catalyze-01 3  times
Seen enzyme 521  times


bio.mskcc_0001.5
Once activated , either by upstream signaling or by mutational events , all Raf proteins are capable of initiating the phosphorylation cascade that results in the sequential activation of MEK and ERK .
FN set(['cascade', 'enzyme', 'follow-01'])

Seen cascade 4  times
Seen enzyme 521  times
Seen follow-01 13  times


bio.mskcc_0001.4
Under normal signaling conditions , Ras activation helps mediate these events by recruiting the Raf proteins to the plasma membrane , which induces the release of 14 @-@ 3 @-@ 3 from the N @-@ terminal binding site and facilitates phosphorylation of the Raf kinase domain ( 19 ) .
FN set(['domain', 'protein-segment', 'kinase', 'enzyme'])

Seen domain 3  times
Seen protein-segment 69  times
Seen kinase 29  times
Seen enzyme 521  times


bio-exp_0001.2
Upregulation of HER3 has been found to mediate resistance to PI3K @/@ AKT ( 26 ) or HER2 ( 27 ) inhibitors in HER2 @-@ amplified breast cancer cell lines , which is caused in part through a FoxO3A @-@ dependent induction of HER3 gene transcription .
FN set(['"pi3k/akt"', 'encode-01', 'mediate-01', 'transcribe-01', 'upregulate-01', 'enzyme', 'pathway'])

Seen encode-01 11  times
Seen mediate-01 21  times
Seen transcribe-01 24  times
Seen enzyme 521  times
Seen pathway 80  times


bio.mskcc_0001.9
Here we find that both normal and oncogenic B @-@ Raf proteins are phosphorylated on four S/TP sites ( S151 , T401 , S750 , and T753 ) by activated ERK .
FN set(['enzyme', 'or'])

Seen enzyme 521  times
Seen or 121  times


bio.mskcc_0001.8
For B @-@ Raf , two ERK @-@ dependent feedback sites , S750 and T753 , have been identified , and phosphorylation of these sites has been reported to have a negative regulatory effect
FN set(['enzyme', 'downregulate-01'])

Seen enzyme 521  times
Seen downregulate-01 33  times


bio-exp_0001.3
As shown in Fig. 5A , PLX4032 treatment increased HER3 and HER2 mRNAs in all six BRAF @-@ mutant thyroid cancer cell lines tested .
FN set(['all', 'test-01', '"6"', 'dna', 'encode-01', 'small-molecule', 'include-91', 'mrna'])

Seen all 14  times
Seen test-01 9  times
Seen "6" 8  times
Seen dna 10  times
Seen encode-01 11  times
Seen small-molecule 89  times
Seen include-91 42  times


bio.mskcc_0001.31
As shown in Fig. 4A , the FBm or S729A mutation had no effect on transformation induced by the V600E or G469A B @-@ Raf protein , both of which possess high kinase activity .
FN set(['feedback', '"g469a"', 'high', 'act-01', 'protein-segment', 'kinase', 'have-part-91', 'enzyme'])

Seen feedback 6  times
Seen high 16  times
Seen act-01 40  times
Seen protein-segment 69  times
Seen kinase 29  times
Seen have-part-91 5  times
Seen enzyme 521  times


bio.mskcc_0001.30
The proteins were then expressed in NIH 3T3 cells and examined for their abilities to alter cell morphology and induce focus formation .
FN set(['"interrogative"', 'possible'])

Seen "interrogative" 18  times
Seen possible 184  times


bio.mskcc_0001.33
The total number of foci observed and , often , the sizes of the foci were increased , and cells within the foci exhibited a more transformed appearance .
FN set(['appear-02', 'focus', 'number'])

Seen appear-02 28  times
Seen number 4  times


bio.mskcc_0001.32
However , mutation of the feedback sites significantly increased the transforming activities of B @-@ Raf proteins with intermediate or impaired kinase activity ( Fig . 4A ) .
FN set(['enzyme', 'significant-02', 'act-01'])

Seen enzyme 521  times
Seen significant-02 5  times
Seen act-01 40  times


bio.mskcc_0001.35
Examination of activated phospho @-@ MEK levels revealed that the FBm and S729 mutations had no effect on MEK activation induced by the high @-@ activity V600E B @-@ Raf protein ; however , the FBm and S729A mutations increased and decreased , respectively , the abilities of the intermediate G466A and kinase @-@ impaired D594G B @-@ Raf proteins to activate MEK ( Fig . 4B ) , indicating a correlation between the transformation potential of these proteins and their ability to activate ERK cascade signaling in vivo .
FN set(['"serine"', 'feedback', '"729"', 'possible', '"v600e"', 'protein-segment', 'amino-acid', 'kinase', 'have-part-91', 'enzyme'])

Seen feedback 6  times
Seen possible 184  times
Seen protein-segment 69  times
Seen amino-acid 51  times
Seen kinase 29  times
Seen have-part-91 5  times
Seen enzyme 521  times


bio.mskcc_0001.34
In contrast , the S729A mutation reduced the transforming activities of the oncogenic proteins with intermediate or impaired kinase activity , causing a reduction in focus number and a flatter cell morphology ( Fig . 4A ) .
FN set(['transform-01', 'focus', 'more'])

Seen transform-01 10  times
Seen more 44  times


bio.mskcc_0001.37
Together , these findings indicate a correlation between the changes in the transformation potentials of the intermediate and impaired oncogenic B @-@ Raf proteins and their abilities to heterodimerize and activate C @-@ Raf .
FN set(['enzyme', 'possible', 'capable-01'])

Seen enzyme 521  times
Seen possible 184  times
Seen capable-01 12  times


bio.mskcc_0001.36
Not unexpectedly , for all of the oncogenic B @-@ Raf proteins , the S729A mutation , which disrupts heterodimerization with C @-@ Raf , caused a >90 % decrease in C @-@ Raf activity levels ( Fig . 5B ) .
FN set(['"90"', 'more-than', 'enzyme', '"s729a"'])

Seen "90" 2  times
Seen more-than 5  times
Seen enzyme 521  times


bio.mskcc_0001.39
The mutant proteins were then examined for their abilities to heterodimerize with C @-@ Raf and to bind activated Ras under conditions where feedback phosphorylation was induced ( in cycling cells for the G466A mutants and in cells treated with PDGF for 30 min for the WT B @-@ Raf mutants ) .
FN set(['small-molecule', '"interrogative"', 'possible', 'enzyme', 'mean-01'])

Seen small-molecule 89  times
Seen "interrogative" 18  times
Seen possible 184  times
Seen enzyme 521  times
Seen mean-01 56  times


bio.mskcc_0001.38
To investigate the contributions of the various feedback sites to the overall effect of feedback phosphorylation on B @-@ Raf function , we generated a panel of mutants in which specific feedback phosphorylation sites were incorporated into either WT B @-@ Raf or the intermediate @-@ activity G466A B @-@ Raf protein .
FN set(['"g466a"', 'incorporate-02', 'thing', 'enzyme', 'act-01', 'cause-01'])

Seen incorporate-02 4  times
Seen thing 97  times
Seen enzyme 521  times
Seen act-01 40  times
Seen cause-01 128  times


bio.bmtr_0002.21
This supports the hypothesis that a dominant ERK feedback on ERBB3/PI3K/AKT is mediated though phosphorylation of T669 on EGFR ( or T677 HER2 ) .
FN set(['enzyme', '"erbb3/pi3k/akt"', 'pathway'])

Seen enzyme 521  times
Seen pathway 80  times


bio.ras_0001.10
Other less frequently observed mutations , such as those found in the G4 and G5 boxes , increase the rate of nucleotide exchange , thereby mimicking the GEFs and increasing the GTP - bound state ( 1 – 7 ) .
FN set(['value-interval', '"ras"', 'number', 'cite-01', 'cause-01', 'protein-segment', 'publication', 'small-molecule', 'attest-01', 'enzyme', 'mutation', 'or'])

Seen value-interval 15  times
Seen "ras" 169  times
Seen number 4  times
Seen cite-01 75  times
Seen cause-01 128  times
Seen protein-segment 69  times
Seen publication 66  times
Seen small-molecule 89  times
Seen enzyme 521  times
Seen or 121  times


bio.mskcc_0001.44
As indicated in Fig. 7A , when PP2A was inhibited with okadaic acid treatment , slower @-@ migrating forms of the V600E , G466A , and D594G B @-@ Raf proteins were found to accumulate .
FN set(['enzyme', 'small-molecule', 'more'])

Seen enzyme 521  times
Seen small-molecule 89  times
Seen more 44  times


bio.mskcc_0001.45
Moreover , given their constitutive phosphorylation on S/TP sites ( Fig . 3D ) , these oncogenic B @-@ Raf mutants were found to interact constitutively with Pin1 ( Fig . 7B ) , indicating that oncogenic B @-@ Raf proteins are dephosphorylated and recycled .
FN set(['"s/tp"', 'enzyme', 'recycle-01'])

Seen enzyme 521  times


bio.mskcc_0001.46
Consistent with the model that Pin1 influences B @-@ Raf signaling by facilitating the dephosphorylation of the feedback sites , overexpression of the Pin1 proteins had no effect on the transformation potential of G466A FBm @-@ B @-@ Raf , which lacks the sites of feedback phosphorylation .
FN set(['"g466a"', 'protein-segment', 'possible', 'have-part-91', 'enzyme', 'too', 'mutate-01'])

Seen protein-segment 69  times
Seen possible 184  times
Seen have-part-91 5  times
Seen enzyme 521  times
Seen too 1  times
Seen mutate-01 148  times


bio.mskcc_0001.47
Previous studies have found that both the C @-@ Raf and B @-@ Raf proteins are targets of ERK @-@ dependent feedback phosphorylation
FN set(['enzyme', 'target-01'])

Seen enzyme 521  times
Seen target-01 50  times


bio.mskcc_0001.40
As shown in Fig. 6A , only mutation of the S151 feedback site , which is in close proximity to the Ras binding domain ( residues 155 to 227 ) , was found to significantly increase binding to activated Ras .
FN set(['domain', 'feedback', 'significant-02', 'enzyme', 'between', 'mean-01'])

Seen domain 3  times
Seen feedback 6  times
Seen significant-02 5  times
Seen enzyme 521  times
Seen between 16  times
Seen mean-01 56  times


bio.mskcc_0001.41
In contrast , mutation of S151A , T401A , and S750A T753A were all found to increase C @-@ Raf binding ( Fig . 6A ) , a finding consistent with peptide studies suggesting that there are multiple points of contact between heterodimerized B @- and C @-@ Raf proteins ( 27 ) .
FN set(['enzyme', '"b-raf"', '"s750a"'])

Seen enzyme 521  times
Seen "b-raf" 5  times


bio.mskcc_0001.42
Interestingly , when the S729A mutation was introduced into the FBm mutant , binding to C @-@ Raf was abolished ( Fig . 6A ) , indicating that the increased heterodimerization observed when the feedback sites are mutated is still dependent on 14 @-@ 3 @-@ 3 binding .
FN set(['"-"', 'interesting', 'have-part-91', 'enzyme', '"b-raf"'])

Seen "-" 218  times
Seen interesting 2  times
Seen have-part-91 5  times
Seen enzyme 521  times
Seen "b-raf" 5  times


bio.mskcc_0001.43
Given that oncogenic B @-@ Raf proteins are targets of feedback phosphorylation , we next examined whether they might also be dephosphorylated and recycled in a manner involving the PP2A phosphatase and the Pin1 prolyl @-@ isomerase .
FN set(['possible', 'enzyme', 'phosphatase', 'recycle-01', 'prolyl-isomerase'])

Seen possible 184  times
Seen enzyme 521  times


bio-exp_0001.6
RAF or MEK inhibitors induced luciferase activity of a HER3 promoter construct spanning ~ 1 kb upstream of the transcriptional start site in 8505C cells .
FN set(['cell', 'enzyme', '"8505s"', 'act-01'])

Seen cell 193  times
Seen enzyme 521  times
Seen act-01 40  times


bio-exp_0001.7
Serial deletions identified a minimal HER3 promoter retaining transcriptional response to vemurafenib and AZD6244 , which was located between -@ 401 and -@ 42 bp ( Fig. 5C ) .
FN set(['"-42"', 'transcribe-01', 'distance-quantity', 'serial', 'small-molecule', '"-401"', 'thing', 'enzyme', 'between', 'base-pair', 'minimal'])

Seen transcribe-01 24  times
Seen distance-quantity 6  times
Seen small-molecule 89  times
Seen thing 97  times
Seen enzyme 521  times
Seen between 16  times


bio-exp_0001.4
Similar results were found following treatment with the MEK inhibitor AZD6244 ( not shown ) .
FN set(['thing', 'enzyme'])

Seen thing 97  times
Seen enzyme 521  times


bio-exp_0001.5
The effects of the MEK inhibitor on total HER2 , HER3 protein and on pHER3 were dose dependent , and inversely associated with the degree of inhibition of pERK ( Fig. 5B ) .
FN set(['dose-01', 'phosphorylate-01', 'thing', 'enzyme'])

Seen phosphorylate-01 38  times
Seen thing 97  times
Seen enzyme 521  times


bio.mskcc_0001.48
In the case of C @-@ Raf , six sites of feedback phosphorylation have been identified , five of which are direct targets of activated ERK ( 8 )
FN set(['protein-segment', 'enzyme', 'direct'])

Seen protein-segment 69  times
Seen enzyme 521  times
Seen direct 15  times


bio.mskcc_0001.49
For B @-@ Raf , previous work by Brummer et al. ( 3 ) identified the C @-@ terminal S750 and T753 residues as sites phosphorylated by activated ERK .
FN set(['cite-01', 'enzyme', 'publication'])

Seen cite-01 75  times
Seen enzyme 521  times
Seen publication 66  times


bio-exp_0001.1
We next examined the mechanisms accounting for the increase in HER3 by MAPK pathway inhibitors in BRAF mutant thyroid cell lines .
FN set(['enzyme', 'dna', 'encode-01'])

Seen enzyme 521  times
Seen dna 10  times
Seen encode-01 11  times


bio.bmtr_0002.9
To test this hypothesis , we transiently transfected CHO @-@ KI cells , which do not express ERBB receptors endogenously , with wild @-@ type ERBB3 with either wild @-@ type EGFR or EGFR T669A .
FN set(['and', 'cell', 'enzyme', 'mutate-01'])

Seen and 729  times
Seen cell 193  times
Seen enzyme 521  times
Seen mutate-01 148  times


bio.bmtr_0004.11
These results indicate that variations in the linker length on this scale ( 1 @-@ 2 bonds ) do not influence the sensitivity of mUbRas to GAP downregulation .
FN set(['sensitive-03', '"ras"', '"2"', 'protein-segment', 'ubiquitinate-01', 'enzyme', 'or', 'bond'])

Seen sensitive-03 5  times
Seen "ras" 169  times
Seen "2" 45  times
Seen protein-segment 69  times
Seen ubiquitinate-01 1  times
Seen enzyme 521  times
Seen or 121  times


bio.bmtr_0002.8
We hypothesized that MEK inhibition activates AKT by inhibiting ERK activity , which blocks an inhibitory threonine phosphorylation on the JM domains of EGFR and HER2 , thereby increasing ERBB3 phosphorylation .
FN set(['enzyme', 'or'])

Seen enzyme 521  times
Seen or 121  times


bio.bmtr_0005.23
Additionally , RAS/Raf/MAPK pathway activation stabilizes ASPP2 protein , although the underlying mechanism remains to be investigated .
FN set(['"ras/raf/mapk"'])



bio.bmtr_0005.22
We show here that ASPP2 is phosphorylated by the RAS/Raf/MAPK pathway and that this phosphorylation leads to its increased translocation to the cytosol @/@ nucleus and increased binding to p53 , providing an explanation of how RAS can activate p53 pro @-@ apoptotic functions ( Figure 5 ) .
FN set(['cytosol', '"ras/raf/mapk"', 'enzyme', 'slash'])

Seen cytosol 2  times
Seen enzyme 521  times
Seen slash 23  times


bio.bmtr_0005.21
Until now , it has been unclear how RAS could affect ASPP2 to enhance p53 function .
FN set(['enzyme', 'cause-01'])

Seen enzyme 521  times
Seen cause-01 128  times


bio.bmtr_0005.20
Moreover , the RAS @-@ ASPP interaction enhances the transcription function of p53 in cancer cells [2].
FN set(['cite-01', '"2"', 'describe-01', 'enzyme', 'publication'])

Seen cite-01 75  times
Seen "2" 45  times
Seen describe-01 404  times
Seen enzyme 521  times
Seen publication 66  times


bio.bmtr_0002.13
We observed analogous results in CHO @-@ KI cells expressing wild @-@ type ERBB3 in combination with wild @-@ type or T677A mutant HER2 ( Figure 6B ) .
FN set(['cell', 'enzyme', 'analogous'])

Seen cell 193  times
Seen enzyme 521  times
Seen analogous 1  times


bio.bmtr_0004.8
We obtained similar results using K @-@ Ras ( Supplementary Figure 6 ) , indicating that the effects of monoubiquitination on Ras are not isoform @-@ specific .
FN set(['enzyme'])

Seen enzyme 521  times


bio.bmtr_0002.19
As expected , addition of AZD6244 failed to further augment ERBB3 and AKT phosphorylation in cells expressing the 669A mutant .
FN set(['"-"', '"669"', 'amino-acid', 'small-molecule', 'enzyme', 'pathway'])

Seen "-" 218  times
Seen amino-acid 51  times
Seen small-molecule 89  times
Seen enzyme 521  times
Seen pathway 80  times


bio.mskcc_0001.22
When we next examined the effect of feedback phosphorylation on the ability of oncogenic B @-@ Raf to form heterodimers with C @-@ Raf , we found that the levels of endogenous C @-@ Raf associating with B @-@ Raf proteins of high ( V600E ) , intermediate ( G466A ) , and impaired ( D594G ) kinase activities all increased when the feedback sites were mutated , indicating that feedback phosphorylation also inhibits the heterodimerization of oncogenic B @-@ Raf proteins ( Fig . 3D ) .
FN set(['kinase', 'possible', 'enzyme', 'endogenous', 'act-01'])

Seen kinase 29  times
Seen possible 184  times
Seen enzyme 521  times
Seen endogenous 8  times
Seen act-01 40  times


bio.mskcc_0001.23
Previous studies have shown that , for both normal and oncogenic B @-@ Raf proteins to heterodimerize with C @-@ Raf , the C @-@ terminal 14 @-@ 3 @-@ 3 binding site of C @-@ Raf ( S621 ) must be intact ( 11 , 27 ) ( Fig . 3E ) .
FN set(['require-01', 'enzyme', 'study'])

Seen require-01 18  times
Seen enzyme 521  times
Seen study 6  times


bio.mskcc_0001.20
These findings support a model whereby feedback phosphorylation disrupts Raf heterodimerization .
FN set(['enzyme'])

Seen enzyme 521  times


bio.mskcc_0001.21
Unlike WT B @-@ Raf , oncogenic B @-@ Raf proteins have been shown to heterodimerize constitutively with C @-@ Raf in a Ras @-@ independent manner ( 11 ) .
FN set(['enzyme', 'contrast-01'])

Seen enzyme 521  times
Seen contrast-01 80  times


bio.mskcc_0001.26
In contrast , S729A B @-@ Raf failed to heterodimerize with C @-@ Raf in response to growth factor treatment , and mutation of this site disrupted the constitutive interaction of oncogenic B @-@ Raf proteins and C @-@ Raf ( Fig . 3F ) , indicating that heterodimerization with C @-@ Raf is dependent on the C @-@ terminal S729 14 @-@ 3 @-@ 3 binding site of B @-@ Raf .
FN set(['enzyme', 'small-molecule', '"s729a"'])

Seen enzyme 521  times
Seen small-molecule 89  times


bio.mskcc_0001.27
Previous studies have found that all oncogenic B @-@ Raf proteins can activate C @-@ Raf and that heterodimerization with C @-@ Raf is required for kinase @-@ impaired oncogenic B @-@ Raf proteins to mediate ERK activation in vivo ( 31 ) .
FN set(['enzyme', 'kinase', 'act-01'])

Seen enzyme 521  times
Seen kinase 29  times
Seen act-01 40  times


bio.mskcc_0001.24
To determine whether binding of 14 @-@ 3 @-@ 3 to B @-@ Raf is also required for heterodimerization , B @-@ Raf proteins containing lanine substitutions in the two 14 @-@ 3 @-@ 3 binding sites , S365 and S729 ( 2 ) , were examined for their abilities to heterodimerize with C @-@ Raf in response to growth factor treatment .
FN set(['small-molecule', '"interrogative"', 'possible', 'enzyme', '"alanine"'])

Seen small-molecule 89  times
Seen "interrogative" 18  times
Seen possible 184  times
Seen enzyme 521  times
Seen "alanine" 2  times


bio.mskcc_0001.25
Not surprisingly , given that mutation of the S365 14 @-@ 3 @-@ 3 binding site enhances the membrane localization of B @-@ Raf ( 2 ) , increased heterodimerization with C @-@ Raf was observed for S365A B @-@ Raf compared to WT B @-@ Raf ( Fig . 3F ) .
FN set(['enzyme', '"s365a"'])

Seen enzyme 521  times


bio.bel_0002.6
siRNA @-@ mediated depletion of B @-@ Raf reduced cell proliferation by up to 65 % through the inhibition of ERK1 @/@ 2 activation , irrespective of the mutational status of B @-@ Raf .
FN set(['rna-region', 'enzyme', '"erk1/2"'])

Seen enzyme 521  times


bio.bmtr_0003.21
The biochemical mechanisms involved in delocalization of CtBPs by MAPK inhibition have not been explored , but posttranslational modifications are known to regulate the repressive activity of CtBPs either by translocation to the cytoplasm or by targeting them for degradation ( 36 , 37 ) .
FN set(['know-01', 'delocalize-00', 'pathway', 'translation', 'act-02', '"ctbp"'])

Seen know-01 16  times
Seen delocalize-00 1  times
Seen pathway 80  times
Seen act-02 19  times


bio.mskcc_0001.28
Therefore , to further investigate both the impact of feedback phosphorylation and the contribution of heterodimerization to oncogenic B @-@ Raf function , we examined the transformation potential of oncogenic B @-@ Raf proteins containing mutations in either the feedback phosphorylation sites ( which exhibit increased heterodimerization ) or the S729 14 @-@ 3 @-@ 3 binding site ( which are unable to heterodimerize ) .
FN set(['enzyme', 'infer-01'])

Seen enzyme 521  times
Seen infer-01 20  times


bio.mskcc_0001.29
For these studies , FBm or S729A mutations were incorporated into a number of oncogenic B @-@ Raf proteins that exhibit various levels of kinase activity .
FN set(['"-"', 'feedback', 'incorporate-02', 'act-01', 'protein-segment', 'study', 'kinase', 'have-part-91', 'enzyme'])

Seen "-" 218  times
Seen feedback 6  times
Seen incorporate-02 4  times
Seen act-01 40  times
Seen protein-segment 69  times
Seen study 6  times
Seen kinase 29  times
Seen have-part-91 5  times
Seen enzyme 521  times


bio.bmtr_0004.19
A major advance was our ability to easily generate mUbRas , modified at a single site , in a form suitable for detailed biophysical studies .
FN set(['"ras"', 'biophysical', '"1"', 'advance', 'protein-segment', 'detail-01', 'enzyme', 'ubiquitinate-01'])

Seen "ras" 169  times
Seen "1" 43  times
Seen protein-segment 69  times
Seen detail-01 2  times
Seen enzyme 521  times
Seen ubiquitinate-01 1  times


bio.bmtr_0004.18
Here we show that monoubiquitination decreases the sensitivity of Ras to GAP @-@ mediated hydrolysis .
FN set(['sensitive-03', 'enzyme'])

Seen sensitive-03 5  times
Seen enzyme 521  times


bio.bel_0002.1
Protein kinase A @-@ dependent phosphorylation of serine 43 within the regulatory domain of Raf @-@ 1 reciprocally potentiates its interaction with Rheb and decreases its interaction with H @-@ Ras .
FN set(['domain', 'enzyme'])

Seen domain 3  times
Seen enzyme 521  times


bio.bmtr_0002.17
When endogenous EGFR was replaced with EGFR ( exon19 del ) wild @-@ type at T669 , MEK inhibition led to significant feedback activation of ERBB3/PI3K/AKT signaling ( Figure 6C ) .
FN set(['enzyme', 'pathway', '"19"', 'exon', '"erbb3/pi3k/akt"', 'endogenous', 'delete-01'])

Seen enzyme 521  times
Seen pathway 80  times
Seen "19" 1  times
Seen endogenous 8  times
Seen delete-01 4  times


bio.bmtr_0004.1
Site @-@ Specific Monoubiquitination Activates Ras by Impeding GTPase Activating Protein ( PMC3537887 )
FN set(['"activating"', 'enzyme', '"protein"', 'publication-91'])

Seen enzyme 521  times
Seen "protein" 10  times
Seen publication-91 136  times


bio.bmtr_0002.12
As a control , we treated CHO @-@ KI cells expressing EGFR T669A with HRG ligand to induce maximal ERBB3 phosphorylation ( Figure 6A ) , indicating that the lack of induction of phospho @-@ ERBB3 in EGFR T669A expressing cells following MEK inhibition was not simply due to the saturation of the system with phospho @-@ ERBB3 .
FN set(['"hrg"', 'saturate-01', 'enzyme', 'mutate-01'])

Seen enzyme 521  times
Seen mutate-01 148  times


bio.bmtr_0002.11
In contrast , the EGFR T669A mutant increased both basal EGFR and ERBB3 tyrosine phosphorylation that was not augmented by MEK inhibition .
FN set(['enzyme'])

Seen enzyme 521  times


bio.mskcc_0001.12
Complex formation between B @-@ Raf and Pin1 correlated with the phosphorylation of B @-@ Raf on S/TP sites ( Fig . 1C ) and this interaction could be blocked when the MEK inhibitor U0126 was used to prevent ERK activation and the S/TP phosphorylation of B @-@ Raf ( Fig . 1D ) .
FN set(['macro-molecular-complex', 'small-molecule', '"s/tp"', 'enzyme'])

Seen macro-molecular-complex 107  times
Seen small-molecule 89  times
Seen enzyme 521  times


bio.bmtr_0005.16
Of the two radioactive peaks , one represented the linker region between the GST and our ASPP2 fragment and the other corresponded to a fragment of the same mass as that containing the second putative phosphorylation site , serine 827 .
FN set(['enzyme', 'equal-01'])

Seen enzyme 521  times
Seen equal-01 16  times


bio.bmtr_0005.17
Hence ASPP2 can be phosphorylated at serine 827 by MAPK1 in vitro .
FN set(['enzyme'])

Seen enzyme 521  times


bio.bmtr_0005.14
Each eluted fraction was measured for its radioactivity content ( Figure 1B , right panel ) .
FN set(['thing', 'right', 'radioactive'])

Seen thing 97  times
Seen right 14  times


bio.ras_0003.1
We utilized an unbiased mass spectrometry - based approach to identify ubiquitination sites of Ras .
FN set(['enzyme'])

Seen enzyme 521  times


bio.bmtr_0005.12
As shown in Figure S1 , histone 2B phosphorylated by p38 SAPK had high levels of incorporated 32P , suggesting that p38 SAPK was active ; while under the same conditions , ASPP2 ( 693 @-@ 1128 ) fragment phosphorylated by p38 SAPK had very low levels of incorporated 32P , indicating that p38 SAPK is not an efficient kinase for ASPP2 phosphorylation .
FN set(['"histone"', 'enzyme', 'have-part-91', 'between', '"32"', 'incorporate-02', 'protein-segment', 'phosphorus', 'amino-acid', 'thing', 'molecular-mass'])

Seen enzyme 521  times
Seen have-part-91 5  times
Seen between 16  times
Seen "32" 5  times
Seen incorporate-02 4  times
Seen protein-segment 69  times
Seen amino-acid 51  times
Seen thing 97  times


bio.bmtr_0005.13
The phosphorylated ASPP2 fragment by MAPK1 was digested by trypsin and fractioned on a high performance liquid chromatography ( HPLC ) .
FN set(['protein-segment', 'enzyme'])

Seen protein-segment 69  times
Seen enzyme 521  times


bio.bel_0002.3
Importantly , we show that wild @-@ type B @-@ RAF can also activate C @-@ RAF .
FN set(['enzyme'])

Seen enzyme 521  times


bio.bmtr_0005.11
When compared to p38 SAPK , MAPK1 was clearly able to phosphorylate the ASPP2 fragment in vitro ( Figure 1B , left and middle panels ) .
FN set(['protein-segment', 'enzyme', 'possible'])

Seen protein-segment 69  times
Seen enzyme 521  times
Seen possible 184  times


bio.ras_0003.6
H @-@ Ras ubiquitination sites were also determined by the same approach .
FN set(['enzyme'])

Seen enzyme 521  times


bio.bmtr_0002.20
These results demonstrate that EGFR T669 phosphorylation is necessary for MEK @/@ ERK to suppress EGFR @-@ mediated activation of ERBB3 .
FN set(['enzyme', 'pathway', '"mek/erk"'])

Seen enzyme 521  times
Seen pathway 80  times


bio.bmtr_0005.18
Passage 1 @-@ 2 ( Discussion/Conclusion )
FN set(['discuss-01', 'thing', 'slash', '"1-2"', 'conclude-01', 'passage'])

Seen discuss-01 4  times
Seen thing 97  times
Seen slash 23  times
Seen conclude-01 3  times


bio.bmtr_0005.19
We and others have recently shown that ASPP2 can potentiate RAS signaling by binding directly via the ASPP2 N @-@ terminus [2,6].
FN set(['value-interval', 'cite-01', '"6"', '"2"', 'signal-07', 'publication', 'potentiate-00', 'describe-01', 'enzyme'])

Seen value-interval 15  times
Seen cite-01 75  times
Seen "6" 8  times
Seen "2" 45  times
Seen signal-07 74  times
Seen publication 66  times
Seen describe-01 404  times
Seen enzyme 521  times


bio.mskcc_0001.17
These findings are similar to what has been observed for C @-@ Raf ( 8 ) and suggest that feedback phosphorylation is a conserved mechanism used to disrupt the Ras @/@ Raf interaction .
FN set(['cite-01', 'publication', 'conserve-01', 'describe-01', 'find-01', 'thing', 'enzyme', '"8"'])

Seen cite-01 75  times
Seen publication 66  times
Seen conserve-01 3  times
Seen describe-01 404  times
Seen find-01 18  times
Seen thing 97  times
Seen enzyme 521  times
Seen "8" 4  times


bio.mskcc_0001.16
Consistent with this model , we found that when purified activated ERK was incubated with kinase @-@ dead B @-@ Raf( K375M ) in vitro , ERK strongly phosphorylated B @-@ Raf on the S151 , S750 , and T753 sites , with phosphorylation of T401 also observed ( Fig . 2B ) .
FN set(['"-"', 'enzyme'])

Seen "-" 218  times
Seen enzyme 521  times


bio.mskcc_0001.15
All four of these identified sites are followed by a proline residue , and their phosphorylation could be blocked by pretreating cells with the MEK inhibitor U0126 ( Fig . 2A ) , suggesting that these residues are feedback targets of the proline @-@ directed kinase , ERK .
FN set(['protein-segment', 'small-molecule', 'treat-04', 'kinase', 'enzyme', 'before'])

Seen protein-segment 69  times
Seen small-molecule 89  times
Seen treat-04 32  times
Seen kinase 29  times
Seen enzyme 521  times
Seen before 5  times


bio.mskcc_0001.14
Eluting in HPLC fractions 78 to 79 was a peptide phosphorylated on S750 and T753 , the previously identified ERK sites , and eluting in fractions 26 and 58 to 59 were peptides phosphorylated at S151 and T401 , respectively .
FN set(['protein-segment', 'hplc', 'enzyme'])

Seen protein-segment 69  times
Seen enzyme 521  times


bio.mskcc_0001.13
Together , these findings indicate that Pin1 is needed for the efficient dephosphorylation of B @-@ Raf and are consistent with the model that S/TP phosphorylation inhibits Raf signaling .
FN set(['and', 'protein-segment', '"s/tp"', 'enzyme'])

Seen and 729  times
Seen protein-segment 69  times
Seen enzyme 521  times


bio.ras_0003.4
His - ubiquitinated K @-@ Ras was subsequently purified with anti - Flag resin .
FN set(['protein-segment', '"flag"', 'enzyme'])

Seen protein-segment 69  times
Seen enzyme 521  times


bio.mskcc_0001.11
The Pin1 prolyl @-@ isomerase binds specifically to phosphorylated S/TP ( pS/TP ) motifs ( 33 ) , and isomerization of the pS @/@ TP bond is required for PP2A to efficiently dephosphorylate certain proteins , such as cdc25C , Myc , and C @-@ Raf ( 16 ) .
FN set(['protein-segment', 'isomerize-00', '"s/tp"', 'enzyme', 'prolyl-isomerase'])

Seen protein-segment 69  times
Seen enzyme 521  times


bio.mskcc_0001.10
Previously , we found that in response to growth factor treatment , signaling from C @-@ Raf is downregulated by ERK @-@ dependent feedback phosphorylation on S/TP sites and that C @-@ Raf is subsequently dephosphorylated and returned to a signaling @-@ competent state through the activities of PP2A and the Pin1 prolyl @-@ isomerase ( 8 )
FN set(['"serine"', 'prolyl-isomerase', 'enzyme', '"threonine"', 'activate-01', 'after', 'amino-acid', 'small-molecule', 'or'])

Seen enzyme 521  times
Seen "threonine" 3  times
Seen activate-01 113  times
Seen after 36  times
Seen amino-acid 51  times
Seen small-molecule 89  times
Seen or 121  times


bio-exp_0001.14
Finally , CtBP1 and CtBP2 chromatin immunoprecipitation assays showed decreased binding to the HER3 promoter after treatment with PLX4032 ( Fig. 5F ) .
FN set(['chromatin', 'small-molecule', 'enzyme', 'immunoprecipitate-00', '"5f"'])

Seen small-molecule 89  times
Seen enzyme 521  times
Seen immunoprecipitate-00 38  times


bio-exp_0001.15
These findings were confirmed in a second cell line ( Supplementary Fig. S5A ) .
FN set([])



bio.bmtr_0002.14
Together these results support the hypothesis that inhibition of ERK @-@ mediated phosphorylation of a conserved JM domain threonine residue leads to feedback activation of EGFR , HER2 , and ERBB3 ( Figure 7 ) .
FN set(['enzyme'])

Seen enzyme 521  times


bio-exp_0001.10
The minimal HER3 promoter region regulated by MAPK inhibitors overlaps with sequences previously described to be immunoprecipitated using antibodies against the ZFN217 transcription factor and CtBP1 @/@ CtBP2 corepressors ( 28–30 ) .
FN set(['value-interval', 'cite-01', 'publication', 'enzyme', 'pathway', 'minimal', '"30"', 'corepressor', '"28"', 'or'])

Seen value-interval 15  times
Seen cite-01 75  times
Seen publication 66  times
Seen enzyme 521  times
Seen pathway 80  times
Seen "30" 11  times
Seen "28" 3  times
Seen or 121  times


bio-exp_0001.11
CtBPs have also been described to negatively regulate transcriptional activity of the HER3 promoter in breast carcinoma cell lines ( 30 ) .
FN set(['enzyme', '"ctbp"'])

Seen enzyme 521  times


bio-exp_0001.12
Silencing of CtBP1 , and to a lesser extent CtBP2 , increased basal HER3 in 8505C cells , and markedly potentiated the effects of PLX4032 ( Fig. 5D and 5E ) .
FN set(['cell', 'enzyme', 'small-molecule'])

Seen cell 193  times
Seen enzyme 521  times
Seen small-molecule 89  times


bio-exp_0001.13
Knockdown of these factors modestly increased basal and PLX4032 - induced HER2 levels , which likely contributes to the remarkable increase in pHER3 we observed ( Fig. 5D and 5E ) .
FN set(['small-molecule', 'phosphorylate-01', '"her3"', 'enzyme'])

Seen small-molecule 89  times
Seen phosphorylate-01 38  times
Seen enzyme 521  times


bio.bmtr_0004.17
It was established recently that monoubiquitination increases the proportion of Ras that is in the activated ( GTP @-@ bound ) state , that monoubiquitination enhances association with the downstream effectors Raf and PI3 @-@ Kinase , and that mutation of the primary site of monoubiquitination impairs oncogenic Ras @-@ mediated tumorigenesis .
FN set(['enzyme', 'small-molecule'])

Seen enzyme 521  times
Seen small-molecule 89  times


bio.ras_0001.8
RasGEFs bind to Ras and lower the transition energy for the nucleotide exchange of the bound GDP for the more abundant cytosolic GTP , whereas RasGAPs bind to Ras and catalyze GTP hydrolysis .
FN set(['macro-molecular-complex', 'small-molecule', 'enzyme', '"rasgef"', 'lower-05', '"rasgap"'])

Seen macro-molecular-complex 107  times
Seen small-molecule 89  times
Seen enzyme 521  times


bio.ras_0001.9
The most prevalent oncogenic mutations in Ras ( Gly12 and Gly13 in the G1 box , and Gln61 in the G3 box ) preserve the GTP bound state by inhibiting intrinsic GTPase activity and by interfering with the ability of GAPs .
FN set(['"gln61"', 'protein-segment', 'small-molecule', 'enzyme', 'mutation', '"gly13"', '"gly12"'])

Seen protein-segment 69  times
Seen small-molecule 89  times
Seen enzyme 521  times


bio.mskcc_0001.19
In addition , when B @-@ Raf feedback phosphorylation was prevented , either by U0126 treatment or by mutation of all the feedback sites , an increase in the basal level of heterodimerization with C @-@ Raf was observed , and heterodimerization in response to growth factor treatment was increased and prolonged ( Fig . 3B and C ) .
FN set(['protein-segment', 'small-molecule', 'enzyme'])

Seen protein-segment 69  times
Seen small-molecule 89  times
Seen enzyme 521  times


bio.ras_0001.1
The most frequently mutated oncogenes in the deadliest cancers responsible for human mortality are KRAS , PIK3CA and BRAF .
FN set(['and', '"braf"', 'kill-01', 'name', 'cancer', '"pik3ca"', 'most', 'human', 'gene', '"kras"'])

Seen and 729  times
Seen kill-01 1  times
Seen name 2394  times
Seen cancer 44  times
Seen most 32  times
Seen human 19  times
Seen gene 106  times


bio.ras_0001.2
Importantly the signaling enzymes encoded by PIK3CA and BRAF are , in part , regulated by direct binding to activated forms of the Ras proteins suggesting that dysregulation of this key step in signaling is critical for tumor formation .
FN set(['enzyme', 'macro-molecular-complex', 'impair-01'])

Seen enzyme 521  times
Seen macro-molecular-complex 107  times
Seen impair-01 5  times


bio.ras_0001.3
Ras acts as a molecular switch that is activated upon GTP loading and deactivated upon hydrolysis of GTP to GDP .
FN set(['enzyme', 'small-molecule'])

Seen enzyme 521  times
Seen small-molecule 89  times


bio.ras_0001.4
This switch mechanism is common to a wide variety of GTP - binding proteins and is mediated by a conserved structure called the G - domain that consists of five conserved G boxes .
FN set(['various', '"g-domain"', 'small-molecule'])

Seen various 2  times
Seen small-molecule 89  times


bio.ras_0001.5
Under physiological conditions , the rate of GDP or GTP release from the G - domain is slow .
FN set(['"g-domain"', 'small-molecule', 'slow-05'])

Seen small-molecule 89  times
Seen slow-05 2  times


bio.ras_0001.6
As a consequence the GDP produced by GTP hydrolysis on Ras is trapped and the bulk of cellular Ras accumulates in the GDP - bound ‘off’ state , despite the high GTP / GDP ratio in the cytosol ( 1 – 3 ) .
FN set(['value-interval', 'deactivate-01', 'cite-01', 'ratio-of', 'publication', 'small-molecule', 'include-91', 'attest-01', 'enzyme'])

Seen value-interval 15  times
Seen deactivate-01 4  times
Seen cite-01 75  times
Seen ratio-of 1  times
Seen publication 66  times
Seen small-molecule 89  times
Seen include-91 42  times
Seen enzyme 521  times


bio.ras_0001.7
Growth factors can turn on Ras by activating Guanine nucleotide Exchange Factors ( GEFs ) or by inhibiting the GTPase Activating Proteins ( GAPs ) or by both mechanisms .
FN set(['and', 'small-molecule', 'enzyme', 'turn-on-13'])

Seen and 729  times
Seen small-molecule 89  times
Seen enzyme 521  times


bio.mskcc_0001.56
Interestingly , these peptide binding studies also indicate that homodimerized B @-@ Raf and C @-@ Raf proteins have multiple contact points ( 27 ) , suggesting that feedback phosphorylation of the Raf proteins may disrupt Raf homodimers as well
FN set(['enzyme', 'homodimerize-00'])

Seen enzyme 521  times


bio.bmtr_0002.7
Mutation of T669 and T677 abrogates MEK inhibitor @-@ induced suppression of ERBB3 Activation
FN set(['enzyme'])

Seen enzyme 521  times


bio.bmtr_0002.6
Together these data indicate that loss of this inhibitory threonine phosphorylation on the JM domains of EGFR and HER2 occurs in cancer cell lines following MEK inhibition , presumably due to differential subcellular localization and @/@ or binding proteins .
FN set(['presume-01', 'lose-01', 'cell', 'enzyme', 'location', 'and-or'])

Seen presume-01 1  times
Seen lose-01 8  times
Seen cell 193  times
Seen enzyme 521  times
Seen location 5  times
Seen and-or 5  times


bio.bmtr_0002.5
Phospho @-@ specific antibodies confirmed that treatment with AZD6244 inhibited phosphorylation of T669 of EGFR and the analogous T677 of HER2 ( Figure 5A ) .
FN set(['enzyme', 'small-molecule'])

Seen enzyme 521  times
Seen small-molecule 89  times


bio.bmtr_0002.4
Targeting both the phosphorylated and non @-@ phosphorylated peptide forms , we detected a 66 % average decrease in EGFR T669 phosphorylation and a 75 % decrease in HER2 T677 phosphorylation upon treatment with AZD6244 ( Figure 5B , Supplemental Figure 8 ) .
FN set(['protein-segment', 'small-molecule', 'enzyme'])

Seen protein-segment 69  times
Seen small-molecule 89  times
Seen enzyme 521  times


bio.bmtr_0003.18
These corepressors have been previously linked to inhibition of HER3 transcription through promoter regions that show overlapping occupancy with ZNF217 , a transcription factor also involved in HER3 regulation ( 30 ) .
FN set(['and', 'corepressor', 'enzyme'])

Seen and 729  times
Seen enzyme 521  times


bio.bmtr_0003.19
Accordingly , knockdown of CTBPs acutely induced HER3 expression and phosphorylation in thyroid cancer cells .
FN set(['enzyme', '"ctbp"'])

Seen enzyme 521  times


bio.bmtr_0002.1
Turke et al. “ MEK inhibition leads to PI3K @/@ AKT activation by relieving a negative feedback on ERBB receptors ” ( PMC3515079 )
FN set(['enzyme', '"pi3k/akt"', 'publication-91'])

Seen enzyme 521  times
Seen publication-91 136  times


bio.bmtr_0003.14
Knockdown of these factors modestly increased basal and PLX4032 @-@ induced HER2 levels , which likely contributes to the remarkable increase in pHER3 we observed ( Fig . 5D and 5E ) .
FN set(['small-molecule', 'phosphorylate-01', '"her3"', 'enzyme'])

Seen small-molecule 89  times
Seen phosphorylate-01 38  times
Seen enzyme 521  times


bio.bmtr_0003.15
Finally , CtBP1 and CtBP2 chromatin immunoprecipitation assays showed decreased binding to the HER3 promoter after treatment with PLX4032 ( Fig . 5F ) .
FN set(['chromatin', 'small-molecule', 'enzyme', 'immunoprecipitate-00'])

Seen small-molecule 89  times
Seen enzyme 521  times
Seen immunoprecipitate-00 38  times


bio.bmtr_0003.16
These findings were confirmed in a second cell line ( Supplementary Fig. S5A ) .
FN set([])



bio.bmtr_0003.17
The increase in expression of HER3 after MAPK inhibition is due to activation of gene transcription , which was associated with a reduction of binding of the transcriptional repressors CTBP1 and CTBP2 to the HER3 gene promoter .
FN set(['encode-01', 'enzyme', 'molecular-physical-entity', 'repress-01', 'pathway'])

Seen encode-01 11  times
Seen enzyme 521  times
Seen molecular-physical-entity 102  times
Seen repress-01 10  times
Seen pathway 80  times


bio.bmtr_0003.10
Moreover , PLX4032 led to an increase in phosphorylation of FoxO1 @/@ 3A between 4–10h after addition of compound ( not shown ) , which is known to promote its dissociation from DNA , and likely discards involvement of these factors as transcriptional regulators of HER3 in response to MAPK pathway inhibition .
FN set(['"foxo1/3a"', '"4"', 'hour', 'small-molecule', 'temporal-quantity', 'enzyme', 'molecular-physical-entity', 'between', '"10"'])

Seen "4" 31  times
Seen hour 16  times
Seen small-molecule 89  times
Seen temporal-quantity 59  times
Seen enzyme 521  times
Seen molecular-physical-entity 102  times
Seen between 16  times
Seen "10" 28  times


bio.bmtr_0003.11
The minimal HER3 promoter region regulated by MAPK inhibitors overlaps with sequences previously described to be immunoprecipitated using antibodies against the ZFN217 transcription factor and CtBP1 @/@ CtBP2 corepressors ( 28–30 ) .
FN set(['value-interval', 'cite-01', 'publication', 'enzyme', 'pathway', 'minimal', '"30"', 'corepressor', 'or', '"28"'])

Seen value-interval 15  times
Seen cite-01 75  times
Seen publication 66  times
Seen enzyme 521  times
Seen pathway 80  times
Seen "30" 11  times
Seen or 121  times
Seen "28" 3  times


bio.bmtr_0003.12
CtBPs have also been described to negatively regulate transcriptional activity of the HER3 promoter in breast carcinoma cell lines ( 30 ) .
FN set(['negative', 'enzyme', 'regulate-01', '"ctbp"'])

Seen negative 3  times
Seen enzyme 521  times
Seen regulate-01 22  times


bio.bmtr_0003.13
Silencing of CtBP1 , and to a lesser extent CtBP2 , increased basal HER3 in 8505C cells , and markedly potentiated the effects of PLX4032 ( Fig . 5D and 5E ) .
FN set(['cell', 'enzyme', 'small-molecule'])

Seen cell 193  times
Seen enzyme 521  times
Seen small-molecule 89  times


bio.bmtr_0004.9
To verify that the differences between the enzymatic and chemical ubiquitination linkers ( seven bonds and five bonds , respectively ) do not alter GAP @-@ responsiveness , we placed an additional cysteine at the c @-@ terminus of Ubiquitin ( Ubiquitin @-@ C77 ) , thereby creating a linker one bond longer than the native linker .
FN set(['"c-terminus"', 'have-purpose-91', 'additional', 'long', 'enzyme', 'respond-01', 'become-01', 'more'])

Seen "c-terminus" 2  times
Seen have-purpose-91 4  times
Seen additional 3  times
Seen long 3  times
Seen enzyme 521  times
Seen respond-01 13  times
Seen become-01 3  times
Seen more 44  times


bio.bmtr_0004.15
These data support our in vitro findings that monoubiquitination increases the population of active , GTP @-@ bound Ras through a defect in sensitivity to GAP @-@ mediated regulation .
FN set(['sensitive-03', 'small-molecule', 'enzyme'])

Seen sensitive-03 5  times
Seen small-molecule 89  times
Seen enzyme 521  times


bio.ras_0003.8
The tryptic peptide with ubiquitination at Lys147 ( K147 ) was the most frequently observed peptide for both K @-@ Ras and H @-@ Ras , while Lys117 appeared as a secondary major ubiquitination site in H @-@ Ras .
FN set(['hydrolyze-01', 'appear-01', '"trypsin"', 'enzyme'])

Seen hydrolyze-01 10  times
Seen appear-01 8  times
Seen enzyme 521  times


bio.bmtr_0002.18
However , replacement with the EGFR ( exon19 del ) T669A mutant led to increased tyrosine phosphorylation of both EGFR and ERBB3 , and activation of PI3K @/@ AKT signaling , mimicking the effect of MEK inhibition ( Figure 6C ) .
FN set(['"pi3k/akt"', 'enzyme', '"19"', 'exon', 'delete-01'])

Seen enzyme 521  times
Seen "19" 1  times
Seen delete-01 4  times


bio.bmtr_0004.14
As seen in Figure 5c , monoubiquitinated K @-@ Ras is less sensitive than the unmodified protein to GAP @-@ mediated GTP hydrolysis .
FN set(['"-"', 'modify-01', 'small-molecule', 'enzyme'])

Seen "-" 218  times
Seen modify-01 5  times
Seen small-molecule 89  times
Seen enzyme 521  times


bio.ras_0003.2
His - tagged ubiquitin and Flag - tagged K @-@ Ras4B ( K @-@ Ras hereafter ) were expressed in HEK293T cells at levels similar to endogenous K @-@ Ras ( Fig. 1B ) and subjected to sequential affinity chromatography .
FN set(['protein-segment', 'sequence', 'enzyme', '"flag"', 'endogenous'])

Seen protein-segment 69  times
Seen sequence 6  times
Seen enzyme 521  times
Seen endogenous 8  times


bio.ras_0003.3
His - ubiquitinated proteins were purified by Co2+ metal affinity chromatography in 8M urea denaturing conditions .
FN set(['molar', 'small-molecule', 'concentration-quantity', '"8"'])

Seen molar 2  times
Seen small-molecule 89  times
Seen concentration-quantity 14  times
Seen "8" 4  times


bio.bmtr_0004.3
We next considered the effect of Ras monoubiquitination on GAP @-@ mediated hydrolysis .
FN set(['enzyme', 'consider-02'])

Seen enzyme 521  times
Seen consider-02 1  times


bio.bmtr_0004.2
Passage 1 @-@ 1 ( Results )
FN set(['thing', '"1-1"', 'passage'])

Seen thing 97  times


bio.bmtr_0004.5
At a GAP @-@ to @-@ Ras ratio of 1 @:@ 500 , we observed an order of magnitude increase in the rate of GTP hydrolysis for unmodified Ras relative to the intrinsic rate of GTP hydrolysis .
FN set(['"-"', 'modify-01', 'equal-01', 'ratio-of', 'about', 'bind-01', '"1/500"', 'small-molecule', 'enzyme', 'product-of', '"10"'])

Seen "-" 218  times
Seen modify-01 5  times
Seen equal-01 16  times
Seen ratio-of 1  times
Seen about 2  times
Seen bind-01 110  times
Seen small-molecule 89  times
Seen enzyme 521  times
Seen product-of 3  times
Seen "10" 28  times


bio.bmtr_0004.4
To this end we compared the rate of GTP hydrolysis for Ras and mUbRas in the presence of the catalytic domains of two GAPs , NF1 ( NF1 @-@ 333 ) and p120GAP( GAP @-@ 334 ) .
FN set(['"nf1-333"', 'bind-01', '"1"', '"gap-334"', 'small-molecule', 'include-91', 'enzyme', 'catalyze-01', 'ubiquitinate-01'])

Seen bind-01 110  times
Seen "1" 43  times
Seen small-molecule 89  times
Seen include-91 42  times
Seen enzyme 521  times
Seen catalyze-01 3  times
Seen ubiquitinate-01 1  times


bio.bmtr_0004.7
Therefore , mUbRas is insensitive to GAP @-@ mediated regulation , similar to an oncogenic Ras @-@ G12V mutation .
FN set(['enzyme', '"1"', 'ubiquitinate-01'])

Seen enzyme 521  times
Seen "1" 43  times
Seen ubiquitinate-01 1  times


bio.ras_0003.5
Following purification , mono @- and di @- ubiquitinated K @-@ Ras appeared to be the major ubiquitination forms , which is consistent with the endogenous K @-@ Ras ubiquitination pattern ( Fig. 1 , A and B ) .
FN set(['or', '"1a"', 'appear-02', 'enzyme', '"1b"', '"2"'])

Seen or 121  times
Seen "1a" 4  times
Seen appear-02 28  times
Seen enzyme 521  times
Seen "1b" 4  times
Seen "2" 45  times


bio.bmtr_0004.16
Passage 1 @-@ 2 ( Discussion/Conclusion )
FN set(['discuss-01', 'thing', 'slash', '"1-2"', 'conclude-01', 'passage'])

Seen discuss-01 4  times
Seen thing 97  times
Seen slash 23  times
Seen conclude-01 3  times


bio.bmtr_0004.6
No increase in the rate of GTP hydrolysis was observed for mUbRas in the presence of the same GAP @-@ to Ras ratio ( Fig . 5b ) .
FN set(['"1"', 'small-molecule', 'enzyme', 'bind-01', 'ubiquitinate-01'])

Seen "1" 43  times
Seen small-molecule 89  times
Seen enzyme 521  times
Seen bind-01 110  times
Seen ubiquitinate-01 1  times


bio.bmtr_0002.16
Of note , this is the same EGFR @-@ mutant cell line in which we observed that EGFR T669 is phosphorylated in MEK @-@ dependent manner ( Figure 5 , Supplemental Figure 8A ) .
FN set(['and', 'enzyme', 'note-02'])

Seen and 729  times
Seen enzyme 521  times
Seen note-02 8  times


bio.bmtr_0002.15
To determine if this feedback model explains the activation of PI3K signaling in EGFR @-@ mutant cancers , we used shRNA to knockdown endogenous EGFR ( which carries an exon 19 deletion ) in the HCC827 NSCLC cell line and replaced with either EGFR ( exon 19 del ) wild @-@ type at T669 , or EGFR ( exon 19 del ) carrying a T669A mutation .
FN set(['macro-molecular-complex', '"interrogative"', 'enzyme', 'exon', 'endogenous'])

Seen macro-molecular-complex 107  times
Seen "interrogative" 18  times
Seen enzyme 521  times
Seen endogenous 8  times


bio.bmtr_0005.15
The fractions representing these radioactive peaks were analysed by mass spectrometry .
FN set(['peak'])



bio.bmtr_0004.10
We measured the rate of GAP @-@ mediated GTP hydrolysis and observed that the response of Ras ligated to Ubiquitin @-@ C77 was identical to Ras ligated to Ubiquitin @-@ G76C ( Fig . 5b ) .
FN set(['small-molecule', '"76"', 'thing', 'enzyme'])

Seen small-molecule 89  times
Seen thing 97  times
Seen enzyme 521  times


Precision 0.80
Recall 0.80
F1 0.80
